Olanzapine Helps with Chemotherapy-Induced Nausea, Vomiting - NCI
An NCI Cancer Currents blog on a large clinical trial that showed an anti-psychotic drug can help prevent nausea and vomiting in patients receiving chemotherapy.
LCT10001280
Rolapitant in the Current Management of Chemotherapy-induced Nausea and Vomiting
Metagenomics and chemotherapy‐induced nausea: A roadmap for future
A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting
Overview of Chemotherapy-Induced Nausea and Vomiting and Evidence-Based Therapies
Should Olanzapine be Advocated Over Conventional Anti-Emetics for
A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting - ScienceDirect
Olanzapine (LY170053), 5-HT2/D1/D2 Antagonist
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting
Nausea and Vomiting and Cancer Treatment - Side Effects - NCI
Olanzapine for Prevention or Management of Chemotherapy-Induced Nausea and Vomiting: A Promising Option
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting. - Abstract - Europe PMC